InvestorsHub Logo
Followers 41
Posts 1956
Boards Moderated 0
Alias Born 03/24/2014

Re: pqr post# 470910

Wednesday, 05/11/2022 10:49:26 AM

Wednesday, May 11, 2022 10:49:26 AM

Post# of 693773
Understand your perspective PQR and certainly agree with some of your points.

Differentiating the "market" reaction driven by false narratives which hurt all of us shareholders is much different than how the TLD readout is being perceived by the medical community.



I happen to believe in spite of suffering a significant financial setback, we/NWBO gained significant ground in validating DCVaxL and approvals will be coming IMO.

Once the publication comes out (along with other PRs) and further presents the case for the amazing trial results, the share price will follow suit.

The NYAS Conference was chosen to give Dr LL the spotlight with NWBO knowing the risks that they were embargoed from diffusing any and all naysayers. I personally applaude LP for giving the spotlight to Dr LL even though due to extenuating circumstances this plan did not pan out.

I am certain both Dr LL and LP will have their day in the sun!

GLTA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News